Zhao Feng, Luppi Bruno, Chao Po-Han, Yang Jinfan, Zhang Ying, Feng Ran, Chan Vanessa, Kannan Ramya, Dong Songtao, Gogoulis Athan, Wang Leo, Lee Angel, Hudson Zachary, Li Shyh-Dar
Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada.
Department of Chemistry, Faculty of Science, The University of British Columbia, Vancouver, Canada.
Biomaterials. 2026 Jan;324:123541. doi: 10.1016/j.biomaterials.2025.123541. Epub 2025 Jul 8.
Messenger RNA (mRNA)-based therapy has become a promising and scalable approach for treating various diseases, and lipid nanoparticles (LNPs) have recently gained prominence as a safe and effective delivery vehicle. LNPs not only protect mRNA from degradation during systemic circulation but also facilitate its intracellular uptake and endosomal release. However, the endosomal release efficiency of standard LNPs has been shown to be poor, limiting the transfection efficiency. Here, we explored incorporating a biodegradable polymer which only contains tertiary amines as a pH-sensitive functional group into LNPs, aiming to introduce the proton sponge effect to facilitate the endosomal release. We developed a series of novel LNP formulations by spiking the polymers with different molecular weights into LNPs at a range of ratios. Our results demonstrated that the polymer-modified LNPs (p-LNPs) maintained a particle size of approximately 80 nm, a neutral surface charge, and an mRNA encapsulation efficiency >90 %, along with increased pH buffering capacity. The optimal p-LNP formulation tripled the cellular uptake and enhanced the endosomal escape efficiency from 20 % to 80 % compared to the standard LNPs. Furthermore, cells treated with the p-LNP formulation at 1 mg/mL showed no cytotoxicity. Upon intravenous administration, the optimal p-LNP formulation loaded with luciferase mRNA significantly increased the transgene expression evidenced by a 100-fold increase in luciferin bioluminescence from the liver compared to the standard LNPs. Moreover, p-LNPs did not elevate inflammatory cytokines in the treated mice, including IFN-gamma, IL1β, TNFα, and IL6.
基于信使核糖核酸(mRNA)的疗法已成为一种治疗各种疾病的有前景且可扩展的方法,脂质纳米颗粒(LNP)最近作为一种安全有效的递送载体而备受关注。LNP不仅能在全身循环过程中保护mRNA不被降解,还能促进其细胞内摄取和内体释放。然而,标准LNP的内体释放效率已被证明较差,限制了转染效率。在此,我们探索将一种仅含有叔胺作为pH敏感官能团的可生物降解聚合物掺入LNP中,旨在引入质子海绵效应以促进内体释放。我们通过将不同分子量的聚合物以一系列比例掺入LNP中,开发了一系列新型LNP制剂。我们的结果表明,聚合物修饰的LNP(p-LNP)保持了约80纳米的粒径、中性表面电荷以及>90%的mRNA包封效率,同时增加了pH缓冲能力。与标准LNP相比,最佳p-LNP制剂使细胞摄取增加了两倍,并将内体逃逸效率从20%提高到了80%。此外,用1毫克/毫升的p-LNP制剂处理的细胞未显示出细胞毒性。静脉注射后,与标准LNP相比,装载荧光素酶mRNA的最佳p-LNP制剂显著增加了转基因表达,肝脏中荧光素生物发光增加了100倍即为明证。此外,p-LNP在治疗的小鼠中未升高炎性细胞因子,包括干扰素-γ、白细胞介素1β、肿瘤坏死因子α和白细胞介素6。